Kura Oncology, Inc. financial data

Symbol
KURA on Nasdaq
Location
12730 High Bluff Drive, Suite 400, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 820 % -45.4%
Debt-to-equity 76.8 % +614%
Return On Equity -52.3 % -29.4%
Return On Assets -29.6 % +18.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86.8M shares +13.3%
Common Stock, Shares, Outstanding 86.8M shares +13.6%
Entity Public Float 1.6B USD +106%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 87.6M shares +1.1%
Weighted Average Number of Shares Outstanding, Diluted 87.6M shares +1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.3M USD
Research and Development Expense 213M USD +54.3%
General and Administrative Expense 90.3M USD +45%
Nonoperating Income (Expense) 24.8M USD +35.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -66.1M USD -30.1%
Income Tax Expense (Benefit) 226K USD
Net Income (Loss) Attributable to Parent -197M USD -8.49%
Earnings Per Share, Basic -2 USD/shares -0.9%
Earnings Per Share, Diluted -2 USD/shares -0.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 81.9M USD +81.4%
Accounts Receivable, after Allowance for Credit Loss, Current 4.57M USD
Assets, Current 660M USD +32.1%
Property, Plant and Equipment, Net 3.91M USD +157%
Operating Lease, Right-of-Use Asset 7.86M USD +22.9%
Other Assets, Noncurrent 10.6M USD +42.4%
Assets 682M USD +32.5%
Accounts Payable, Current 1.7M USD -17.4%
Employee-related Liabilities, Current 10M USD +12.4%
Contract with Customer, Liability, Current 49.4M USD
Liabilities, Current 107M USD +220%
Contract with Customer, Liability, Noncurrent 253M USD
Operating Lease, Liability, Noncurrent 8.16M USD +39.6%
Other Liabilities, Noncurrent 2.6M USD +121%
Liabilities 377M USD +669%
Accumulated Other Comprehensive Income (Loss), Net of Tax 711K USD
Retained Earnings (Accumulated Deficit) -1.02B USD -24%
Stockholders' Equity Attributable to Parent 305M USD -34.5%
Liabilities and Equity 682M USD +32.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -71.9M USD -47.3%
Net Cash Provided by (Used in) Financing Activities 143K USD
Net Cash Provided by (Used in) Investing Activities -101M USD -6.37%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 86.8M shares +13.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -173M USD -4235%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81.9M USD +81.4%
Deferred Tax Assets, Valuation Allowance 279M USD +24.4%
Deferred Tax Assets, Gross 281M USD +23.9%
Operating Lease, Liability 9.85M USD +34.8%
Depreciation 241K USD +2.99%
Payments to Acquire Property, Plant, and Equipment 292K USD +248%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -196M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 25.1M USD +140%
Property, Plant and Equipment, Gross 7.65M USD +74.5%
Operating Lease, Liability, Current 1.7M USD +15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.53M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.53M USD -21.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +9.01%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.3M USD +198%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.66M USD +167%
Deferred Tax Assets, Operating Loss Carryforwards 97.6M USD -32.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 15.4M USD +52.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.75M USD +169%
Operating Lease, Payments 400K USD -20%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 6.95M USD -17.6%
Interest Expense 1.6M USD +4.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%